LALPATHLAB vs METROPOLIS: Stock Comparison
Head-to-head financial and trading comparison between Dr. Lal Path Labs Ltd. (LALPATHLAB) and Metropolis Healthcare Limited (METROPOLIS) in the Hospitals & Diagnostics sector.
LALPATHLAB
NSE: LALPATHLABMETROPOLIS
NSE: METROPOLISKey Metrics Comparison Table
| Metric | LALPATHLAB | METROPOLIS | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹2,005.10 | ₹537.90 | — |
| 1-Year Price Return | +42.74% | +14.91% | LALPATHLAB (27.83% higher) |
| 52-Week High | ₹2,005.10 | ₹602.10 | — |
| 52-Week Low | ₹1,367.20 | ₹462.35 | — |
| 30-Day Annualized Volatility | 16.31% | 25.35% | LALPATHLAB (Steadier) |
| 30-Day Average Daily Volume | 298,732 | 272,631 | LALPATHLAB (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between LALPATHLAB and METROPOLIS, which stock gave better returns over the last year?
LALPATHLAB has outperformed METROPOLIS over the past 12 months with a gain of 42.74% compared to 14.91%.
Which stock is less volatile: LALPATHLAB or METROPOLIS?
LALPATHLAB demonstrated lower price volatility (16.31% annualized) compared to METROPOLIS (25.35%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of LALPATHLAB vs METROPOLIS?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are LALPATHLAB and METROPOLIS direct sector competitors?
Yes, both companies operate within the Hospitals & Diagnostics sector in India and are actively tracked as sector peers by institutional and retail market participants.